Wuhan General Gr Valuation
| WUHNDelisted Stock | USD 0.0004 0.00 0.00% |
Wuhan General seems to be overvalued based on Macroaxis valuation methodology. Our model calculates the value of Wuhan General Gr from examining the company fundamentals such as Profit Margin of (0.13) %, current valuation of 3.05 M, and Return On Asset of -0.005 as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Wuhan General's price fluctuation is very steady at this time. Calculation of the real value of Wuhan General Gr is based on 3 months time horizon. Increasing Wuhan General's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Wuhan General is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Wuhan Pink Sheet. However, Wuhan General's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.0E-4 | Real 3.8E-4 | Hype 5.0E-4 |
The intrinsic value of Wuhan General's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Wuhan General's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Wuhan General Gr helps investors to forecast how Wuhan pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Wuhan General more accurately as focusing exclusively on Wuhan General's fundamentals will not take into account other important factors: Wuhan General Total Value Analysis
Wuhan General Gr is at this time forecasted to have valuation of 3.05 M with market capitalization of 3.05 M, debt of 118.8 M, and cash on hands of 18.79 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Wuhan General fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.05 M | 3.05 M | 118.8 M | 18.79 M |
Wuhan General Investor Information
The company has Price to Book (P/B) ratio of 0.04. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Wuhan General Gr recorded a loss per share of 0.35. The entity had not issued any dividends in recent years. The firm had 1:2000 split on the 28th of December 2006. Based on the analysis of Wuhan General's profitability, liquidity, and operating efficiency, Wuhan General Gr is not in a good financial situation at this time. It has a very high odds of going through financial crisis in December.Wuhan General Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The recent return on assets of Wuhan suggests not a very effective usage of assets in November.Wuhan General Profitability Analysis
The company reported the previous year's revenue of 80.38 M. Net Loss for the year was (10.59 M) with profit before overhead, payroll, taxes, and interest of 14.54 M.About Wuhan General Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Wuhan General Gr. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Wuhan General Gr based exclusively on its fundamental and basic technical indicators. By analyzing Wuhan General's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Wuhan General's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Wuhan General. We calculate exposure to Wuhan General's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Wuhan General's related companies.Wuhan General Group , Inc., through its subsidiaries, researches, develops, and commercializes a range of cannabidiol -based products under the Dr. Wuhan General Group , Inc. is headquartered in Pointe-Claire, Canada. Wuhan General operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 700 people.
8 Steps to conduct Wuhan General's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Wuhan General's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Wuhan General's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Wuhan General's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Wuhan General's revenue streams: Identify Wuhan General's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Wuhan General's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Wuhan General's growth potential: Evaluate Wuhan General's management, business model, and growth potential.
- Determine Wuhan General's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Wuhan General's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Wuhan General Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Retained Earnings | 14.6 M | |
| Shares Float | 11.8 M |
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Consideration for investing in Wuhan Pink Sheet
If you are still planning to invest in Wuhan General Gr check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Wuhan General's history and understand the potential risks before investing.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |